Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ticagrelor Intervention to Suppress Stent Thrombosis and Acute MI Risk (TISSARA) Trial: An LMIC Health System Initiative in the World's Busiest Primary PCI Center

NCT06667349 is registered in ClinicalTrials.gov with National Institute of Cardiovascular Diseases, Pakistan as lead sponsor.

NCT NCT06667349
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06667349 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ticagrelor Intervention to Suppress Stent Thrombosis and Acute MI Risk (TISSARA) Trial: An LMIC Health System Initiative in the World's Busiest Primary PCI Center
Lead sponsor
National Institute of Cardiovascular Diseases, Pakistan
Phase
Phase 4
Overall status
Completed
Start date
August 24, 2023
Completion date
June 16, 2024
Enrollment
1,727 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

antiplatelet agents, stemi - st elevation myocardial infarction, stent thrombosis